[EN] BIARYL DERIVATIVES AS NACHR MODULATORS<br/>[FR] DÉRIVÉS DE BIARYLE EN TANT QUE MODULATEURS DE NACHR
申请人:LUPIN LTD
公开号:WO2013005153A1
公开(公告)日:2013-01-10
Disclosed is a compound of formula (I): wherein 'D', Έ', 'm', 'n' and R1-R4 are as described herein, as a modulator of nicotinic acetylcholine receptors particularly the α7 subtype, in a subject in need thereof, as well as analogues, prodrugs, isotopically substituted analogs, metabolites, pharmaceutically acceptable salts, polymorphs, solvates, isomers, clathrates, and co-crystal thereof, for use either alone or in combinations with suitable other medicaments, and pharmaceutical compositions containing such compounds and analogues. Also disclosed are a process of preparation of the compounds and the intended uses thereof in therapy, particularly in the prophylaxis and therapy of disorders such as Alzheimer's disease, mild cognitive impairment, senile dementia, and the like.
本发明涉及一种化合物,其化学式为(I):其中'D'、Έ'、'm'、'n'和R1-R4如本文所述,作为尼古丁型乙酰胆碱受体的调节剂,特别是α7亚型,在需要的受试者中使用,以及类似物、前药、同位素替代物、代谢物、药学上可接受的盐、多晶型、溶剂合物、异构体、包合物和共晶物,可以单独使用或与适当的其他药物组合使用,并含有这种化合物和类似物的药物组合物。还公开了这些化合物的制备过程和它们在治疗中的预期用途,特别是在预防和治疗阿尔茨海默病、轻度认知障碍、老年性痴呆症等疾病方面的用途。